Evidence map›Paper›PMID 30984523›Full record

ArticleBalkan journal of medical genetics : BJMG2018

Myotonic Dystrophy-2: Unusual Phenotype Due to a Small CCTG-expansion.

Finsterer J, Stöllberger C, Reining-Festa A, Loewe-Grgurin M, Gencik M

Open access · goldAbstract read
In one paragraph

Article in Balkan journal of medical genetics : BJMG, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Endometriosis as Initial Manifestation of Myotonic Dystrophy Type-2.Journal of neurosciences in rural practice · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Finsterer JKrankenanstalt Rudolfstiftung, Messerli Institute, Veterinary University of Vienna, Vienna Austria.
Stöllberger CDepartment of Neurology, Krankenanstalt Rudolfstiftung, Vienna, Austria.
Reining-Festa ANeurological Department, Krankenanstalt Rudolfstiftung, Vienna, Austria.
Loewe-Grgurin MRadiological Department, Krankenanstalt Rudolfstiftung, Vienna, Austria.
Gencik MLaboratory for Human Genetics, Vienna, Austria.
Krankenanstalt Rudolfstiftung der Stadt Wien · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myotonic dystrophy type 2 (MD2) is a multisystem disease, predominantly affecting the proximal limb muscles, eyes, endocrine organs, heart and intestines. Longterm asymptomatic creatine kinase (hyper-CKemia) of more than 20 years duration, in association with hyperlipidemia and diabetes, as a manifestation of MD2 has not been reported. A 52-year-old female with a history of hyper-CKemia since the age of 32 years associated with diabetes, hyperlipidemia and hyperuricemia, developed anginal chest pain and proximal muscle weakness together with clinical myotonia when opening the fists at age 51 years. Examination revealed a left anterior hemiblock, sensorimotor neuropathy, extensive myotonic discharges on needle electromyography (EMG) and a CCTG-expansion of 134 bp on the

Indexed as

Cardiac involvementCreatine kinase (hyper-CKemia)Multisystem diseaseMyotoniaNeuromuscularZNF9 gene

Identifiers

PMID30984523
PMCPMC6454246
OpenAlexW2929762154

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.